Levoleucovorin
Small Molecule
Overview
Levoleucovorin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1908841).
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Levoleucovorin expires 25 Mar 2039. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
- Canonical SMILES
- C1[C@@H](N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- InChIKey
- VVIAGPKUTFNRDU-STQMWFEESA-N
Verified Supplier Partner
Do you supply Levoleucovorin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.